0001236031-14-000032.txt : 20140807 0001236031-14-000032.hdr.sgml : 20140807 20140807154913 ACCESSION NUMBER: 0001236031-14-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140806 FILED AS OF DATE: 20140807 DATE AS OF CHANGE: 20140807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 141023662 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-08-06 0 0000725363 CEL SCI CORP cvm 0001236030 KERSTEN GEERT R 1 1 0 0 Chief Executive Officer Common Stock 2014-08-06 4 A 0 5800000 1.09 A 6537310 D The shares were issued pursuant to the Company's 2014 Incentive Stock Bonus Plan. The shares are subject to forfeiture (unless certain performance goals are met) and/or accelerated vesting (in the event of a change in control) as described in the Company's proxy statement filed with the SEC on May 30, 2014. Geert Kersten 2014-08-07